JP2023540558A5 - - Google Patents
Info
- Publication number
- JP2023540558A5 JP2023540558A5 JP2023515088A JP2023515088A JP2023540558A5 JP 2023540558 A5 JP2023540558 A5 JP 2023540558A5 JP 2023515088 A JP2023515088 A JP 2023515088A JP 2023515088 A JP2023515088 A JP 2023515088A JP 2023540558 A5 JP2023540558 A5 JP 2023540558A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- independently selected
- ring
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020113758 | 2020-09-07 | ||
| CNPCT/CN2020/113758 | 2020-09-07 | ||
| PCT/CN2021/116684 WO2022048665A1 (en) | 2020-09-07 | 2021-09-06 | Heterocyclic glp-1 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540558A JP2023540558A (ja) | 2023-09-25 |
| JP2023540558A5 true JP2023540558A5 (cg-RX-API-DMAC10.html) | 2024-09-12 |
| JP7821785B2 JP7821785B2 (ja) | 2026-02-27 |
Family
ID=80491636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515088A Active JP7821785B2 (ja) | 2020-09-07 | 2021-09-06 | ヘテロ環glp-1アゴニスト |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230322771A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4211133A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7821785B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN116615430A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022048665A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021219019A1 (en) | 2020-04-29 | 2021-11-04 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| PE20231181A1 (es) | 2020-08-06 | 2023-08-11 | Gasherbrum Bio Inc | Agonistas del glp-1 heterociclicos |
| WO2022052958A1 (en) | 2020-09-10 | 2022-03-17 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| KR20240053617A (ko) | 2021-08-30 | 2024-04-24 | 민드랭크 에이아이 리미티드 | Glp1r 작용제로서의 신규 아릴 에테르 치환 헤테로시클릭 화합물 |
| SI4408840T1 (sl) | 2021-09-27 | 2025-12-31 | Terns Pharmaceuticals, Inc. | Benzimidazolne karboksilne kisline kot agonisti GLP-1R |
| US12024507B2 (en) | 2021-10-25 | 2024-07-02 | Terns Pharmaceuticals, Inc. | Compounds as GLP-1R agonists |
| AU2023224854A1 (en) | 2022-02-23 | 2024-10-03 | Terns Pharmaceuticals, Inc. | Compounds as glp-1r agonists |
| JP2025510741A (ja) * | 2022-03-21 | 2025-04-15 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環式glp-1アゴニスト |
| PE20250009A1 (es) * | 2022-05-11 | 2025-01-07 | Lilly Co Eli | Composiciones de comprimidos de glp1 |
| US20260217707A1 (en) * | 2023-01-17 | 2026-07-30 | Fochon Biosciences, Ltd. | Glp-1r agonists and uses thereof |
| KR20250168210A (ko) * | 2023-02-16 | 2025-12-02 | 가셔브룸 바이오, 인크. | 헤테로시클릭 glp-1 효능제 |
| PE20252787A1 (es) | 2023-04-07 | 2025-12-22 | Terns Pharmaceuticals Inc | Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica |
| CN119630663B (zh) * | 2023-06-29 | 2025-10-21 | 韦恩生物科技有限公司 | 一种glp-1受体激动剂及其制备方法和用途 |
| TW202506108A (zh) * | 2023-06-30 | 2025-02-16 | 大陸商正大天晴藥業集團股份有限公司 | 含多稠環結構的化合物 |
| AU2024317579A1 (en) * | 2023-07-28 | 2026-02-05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Benzo nitrogen-containing heterocyclic derivative regulator, preparation method therefor and use thereof |
| WO2025026436A1 (zh) * | 2023-08-02 | 2025-02-06 | 韦恩生物科技有限公司 | 一种含氮并环化合物及其制备方法和用途 |
| EP4771001A1 (en) * | 2023-08-31 | 2026-07-08 | Gasherbrum Bio, Inc. | Heteroaryl-heterocycloalkyl-based glp-1 agonists |
| EP4777197A2 (en) | 2023-09-14 | 2026-07-22 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025097835A1 (zh) * | 2023-11-10 | 2025-05-15 | 重庆医药工业研究院有限责任公司 | 一种glp-1r激动剂化合物及其应用 |
| KR20260118441A (ko) | 2023-11-21 | 2026-07-30 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 헤테로시클릭 화합물, 이의 제조 방법 및 의약에서 이의 응용 |
| WO2025109387A1 (en) | 2023-11-24 | 2025-05-30 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| AU2024394361A1 (en) * | 2023-12-05 | 2026-06-18 | Fortvita Biologics Inc. | Glp-1 receptor targeting compounds and uses thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| TW202600132A (zh) | 2024-03-08 | 2026-01-01 | 美商安尼波那生物公司 | 用於治療肥胖症及提高減重之方法 |
| WO2025209515A1 (zh) * | 2024-04-03 | 2025-10-09 | 广州市联瑞制药有限公司 | 一种glp-1受体激动剂及其制备方法和应用 |
| WO2025264023A1 (en) * | 2024-06-19 | 2025-12-26 | Chong Kun Dang Pharmaceutical Corp. | Glp-1 receptor agonist, and uses thereof |
| WO2026031819A1 (en) * | 2024-08-06 | 2026-02-12 | Insilico Medicine Ip Limited | Novel compounds as glp-1r agonists and uses thereof |
| WO2026086876A1 (zh) * | 2024-10-23 | 2026-04-30 | 郑州同源康医药有限公司 | 作为glp-1r激动剂的化合物 |
| WO2026096330A1 (en) * | 2024-10-28 | 2026-05-07 | Merck Sharp & Dohme Llc | Glp-1 receptor agonists and methods of use |
| CN119176808B (zh) * | 2024-11-25 | 2025-12-26 | 山东法恩新材料科技有限公司 | 一种glp-1激动剂及其制备方法和应用 |
| WO2026145540A1 (zh) * | 2024-12-31 | 2026-07-09 | 正大天晴药业集团股份有限公司 | 含多稠环结构的化合物的结晶及其制备方法 |
| WO2026158226A1 (zh) * | 2025-01-21 | 2026-07-30 | 歌礼制药(中国)有限公司 | 一种glp-1r激动剂的注射剂及其制备方法 |
| WO2026158232A1 (zh) * | 2025-01-21 | 2026-07-30 | 歌礼制药(中国)有限公司 | 一种包含glp-1r激动剂的药物组合物及其制备方法 |
| WO2026158353A1 (zh) * | 2025-01-23 | 2026-07-30 | 联邦生物科技(珠海横琴)有限公司 | 具有glp-1受体激动剂效应的杂环化合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927214B1 (en) * | 1999-01-15 | 2005-08-09 | Novo Nordisk A/S | Non-peptide GLP-1 agonists |
| JOP20190060A1 (ar) * | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| JP7461104B2 (ja) * | 2017-11-29 | 2024-04-03 | 中外製薬株式会社 | Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
-
2021
- 2021-09-06 US US18/044,196 patent/US20230322771A1/en active Pending
- 2021-09-06 CN CN202180073815.0A patent/CN116615430A/zh active Pending
- 2021-09-06 JP JP2023515088A patent/JP7821785B2/ja active Active
- 2021-09-06 EP EP21863727.0A patent/EP4211133A4/en active Pending
- 2021-09-06 WO PCT/CN2021/116684 patent/WO2022048665A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540609A5 (cg-RX-API-DMAC10.html) | ||
| JP2023513272A5 (cg-RX-API-DMAC10.html) | ||
| JP2023538949A5 (cg-RX-API-DMAC10.html) | ||
| JP2023524493A5 (cg-RX-API-DMAC10.html) | ||
| JP2023537501A5 (cg-RX-API-DMAC10.html) | ||
| JP2023546055A5 (cg-RX-API-DMAC10.html) | ||
| JP2023515404A5 (cg-RX-API-DMAC10.html) | ||
| JP2025509281A5 (cg-RX-API-DMAC10.html) | ||
| JP2023546054A5 (cg-RX-API-DMAC10.html) | ||
| WO2022031994A1 (en) | Glp-1r agonists and uses thereof | |
| KR102939810B1 (ko) | 과혈당증의 치료에 사용하기 위한 헤테로아릴 치환된 베타-히드록시에틸아민 | |
| TWI222971B (en) | Antagonists of MCP-1 function and methods of use thereof | |
| JP2025510741A5 (cg-RX-API-DMAC10.html) | ||
| CA3176569A1 (en) | Treatment of type 2 diabetes or obesity or overweight with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof | |
| JP2024514010A5 (cg-RX-API-DMAC10.html) | ||
| JP2004503531A (ja) | 2−シアノピロリジン誘導体および薬剤としてのそれらの使用 | |
| EP1396493A1 (en) | Heterocyclic compounds | |
| JP2025506474A5 (cg-RX-API-DMAC10.html) | ||
| JP2026504883A (ja) | Glp-1rアゴニスト及びその使用 | |
| CN111148731A (zh) | 氟苯基β-羟乙胺及其在治疗高糖血症中的用途 | |
| CN111164072A (zh) | β-羟基杂环胺及其在治疗高糖血症中的用途 | |
| KR20210141622A (ko) | 과혈당증의 치료에 유용한 헤테로시클릴(페닐)메탄올 화합물 | |
| JP2025512995A5 (cg-RX-API-DMAC10.html) | ||
| KR20220002903A (ko) | 과혈당증의 치료에 유용한 헤테로아릴(헤테로시클릴)메탄올 화합물 | |
| US7081473B2 (en) | Agent for preventing/ameliorating obesity comprising methylidene hydrizide compound as active ingredient |